300171 Tofflon Science and Technology Group

Dongfulong (300171): Revenue continues to grow steadily

05-19 00:00

Dongfulong (300171): Revenue increased 29.6% year-on-year in the third quarter alone and continued to promote internationalization & diversification

11-02-2022 00:00:00

Dongfulong (300171): The pace of Q3 order delivery is improving, starting a new round of capacity expansion

10-28-2022 00:00:00

Dongfulong (300171): Revenue side growth is in line with expectations, short-term gross margin falls, putting pressure on profit side

10-27-2022 00:00:00

Dongfulong (300171): Pharmaceutical equipment leader creates second growth curve for consumables, CGT, etc.

10-20-2022 00:00:00

Dongfulong (300171) In-depth Report: Jiaolong's Whole Industry Integration Strategy Breaks the Cycle When Going Overseas

10-16-2022 00:00:00

Dongfulong (300171): The epidemic disrupts growth, slows down production capacity optimization, unleashes potential

09-03-2022 00:00:00

Dongfulong (300171): Expectations that overseas business will continue to develop throughout the year without changing the impact of the epidemic

08-31-2022 00:00:00

East Fulong (300171): the company's overall performance is under pressure due to the impact of the steady epidemic situation in the second quarter.

08-30-2022 18:36:46

East Fulong (300171): the performance is in line with the expected overseas growth in the context of the epidemic, which is expected to open up room for long-term growth.

08-30-2022 14:41:42